Page 2 - Virus Replicates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Changer. this drug works by mechanisms that are well understood and there are other drugs that work by similar mechanisms and it works by inducing errors in how the virus replicates and it makes mistakes in replication and it basically kills the virus. these are druggable targets. this virus is well understood. so i think we will get an oral drug that can inhibit viral replication and be taken early in the course of disease to either prevent progression or be used as a prophylaxis. >> so let's be -- just drill down on that a little bit. this could be something -- is this something that people ...

Crosses. but who don't want to have a shot. don't want the vaccine. this is not the vaccine. i mean, is this the vaccine in a pill? >> no. this can be used in conjunction with the vaccine. um, and it's not an alternative to vaccination. we still have to try to get more people vaccinated but there's going to be people who get vaccinated who are breakthrough infections and still develop symptomatic disease. they're at risk. there is going to be people who choose not to get vaccinated for whom this can be effective. but it's going to be used like we use tamiflu. people get vaccinated for flu but ...

Around hydroxychloroquine, the reason there was hype, could you give something to people who were mildly, moderately ill, a pill they could take at home and prevent them from going to the hospital. everybody thought it is a pipe dream, remdesivir came close, but further trial results did not show it as promising. hydroxychloroquine was problematic, harmful to patients. monoclonal antibodies was the only thing that could do that, requires an infusion, about 2,000 bucks a dose. here you talk about five days, twice a day of a pill that could potentially what it does, it basically interferes with ...

That— are four major risks. the first is that that — are four major risks. the first is that that translates to some extent into hospitalisations and deaths, which _ into hospitalisations and deaths, which i _ into hospitalisations and deaths, which i will talk about more. that is protected by the vaccine, but not completely. the second is that there will he _ completely. the second is that there wiii he an— completely. the second is that there will be an increased risk of long—term complications, so—called lon- long—term complications, so—called iong covid — long—term compli...